AI Maverick Intel Inc AIMV

$0.08 +0.00 (0.91%)

Valuation

Market cap
—
Revenue TTM
$0
Net income TTM
$0
P/E (trailing)
—
P/E (forward)
—
Profit margin
0.00%
Debt to equity
—

Trading

Volume
100
Avg volume
28,112
Day's range
$0.08 – $0.08
Shares out
—
Stochastic %K
55%
Beta
—
Analysts
—
Price target
—

Price

Company profile

AI Maverick Intel, Inc., an AI company, focuses on acquiring and enhancing businesses through its proprietary AI Maverick platform. Its technology streamlines the customer acquisition process by automating two way communication and data-driven engagement with its clients ideal audience segments across healthcare, biotech, and other sectors. The company was formerly known as Bionoid Pharma Inc. and changed its name to...

Show more

AI Maverick Intel, Inc., an AI company, focuses on acquiring and enhancing businesses through its proprietary AI Maverick platform. Its technology streamlines the customer acquisition process by automating two way communication and data-driven engagement with its clients ideal audience segments across healthcare, biotech, and other sectors. The company was formerly known as Bionoid Pharma Inc. and changed its name to AI Maverick Intel, Inc. in April 2025. AI Maverick Intel, Inc. was incorporated in 2006 and is based in Mississauga, Canada.

Industry
Medical Devices
Sector
Healthcare
Phone
905 505 0770
Website
https://aimaverickintel.com
Address
5480 Glen Erin Drive, Unit 105, Mississauga, Canada

Latest news

No headlines yet.